ArticleOpen heart2025
Adherence to the European Society of Cardiology hypertension guidelines over 12 years of follow-up in the Irish population.
Article in Open heart, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Closing the hypertension gap with ABPM: a primary care quality-improvement study.BMC primary care · 2026Article
- Longitudinal associations between treatment adherence patterns and blood pressure control among rural hypertensive patients in Central China: a real-world retrospective cohort study.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertension is a significant risk factor for cardiovascular disease, dementia and chronic kidney disease (CKD). Older adults bear the brunt of these conditions, and managing hypertension can be especially challenging in this cohort. In this study, we apply the European Society of Cardiology (ESC) hypertension guidelines to adults ≥50 years participating in a nationally-representative longitudinal study on ageing, providing crucial context for guideline implementation among older adults.
methodsData from waves 1 (2009-2010), 3 (2014-2015) and 6 (2021-2023) of The Irish Longitudinal Study on Ageing were analysed. Hypertension (blood pressure (BP) ≥140/90 mm Hg) prevalence, awareness, treatment, control (on-treatment BP <130/80 mm Hg) and adherence to ESC recommendations were assessed. Subgroup analyses included people aged ≥85 years, adults with frailty, with CKD and with home BP measurements. Data were analysed using Stata V.15.1 applying inverse probability weighting.
resultsFrom wave 3 (n=5329), weighted hypertension prevalence was 64.0% (62.4-65.6%). Of these, 55.5% were aware and 70.3% were on antihypertensive treatment. 32.2% on treatment had controlled BP, 20.9% were on dual therapy and 55.2% were taking one ESC-recommended agent. 87.8%, 77.1% and 76.7% of those with hypertension at waves 1, 3 and 6 were undiagnosed, untreated or uncontrolled. Hypertension prevalence was 91.1% (84.7-95.0%) in people ≥85 years and 75.9% (69.3-81.5%) in moderate-severe frailty.
conclusionsIn a nationally-representative sample of older Irish adults, there is a high prevalence of hypertension, with low awareness, control and adherence to ESC guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.